对照组bmd无明显改变。
Women in the placebo group, not on an aromatase inhibitor, maintained BMD at the spine, but had a significant 1.2% loss at the total hip.
未服用芳香化酶抑制剂的妇女脊柱骨密度保持不变，全髋关节下降1.2%。
The women taking potassium citrate showed significant increases in BMD at the spine and hip compared with the women given potassium chloride.
与服用氯化钾的女性相比，服用枸橼酸钾的女性的脊骨及髋骨表现骨矿物质密度明显升高。
Clinical studies in humans have shown that the prevalence of knee and hip osteoarthritis increases with increasing BMD.
人类临床研究表明随着增加的BMD，膝和臀骨关节炎发病率增加。
BMD was measured at the posteroanterior lumbar spine 1-4, left femoral neck, femoral shaft, trochanter and total hip by dual-energy X-ray absorptiometry (DXA).
双能X线吸收法(DXA)测量后前位第1 - 4腰椎，左侧股骨颈、股骨干、大转子及总股骨的BMD。
BMD was measured at the posteroanterior lumbar spine 1-4, left femoral neck, femoral shaft, trochanter and total hip by dual-energy X-ray absorptiometry (DXA).
双能X线吸收法(DXA)测量后前位第1 - 4腰椎，左侧股骨颈、股骨干、大转子及总股骨的BMD。
应用推荐